ClinicalTrials.Veeva

Menu

Testing Integrative Smoking Cessation for HIV Patients

University of Miami logo

University of Miami

Status and phase

Completed
Phase 4

Conditions

HIV Infections
Smoking
Smoking Cessation

Treatments

Behavioral: Contingency Management Smoking Cessation Intervention
Behavioral: Mindfulness Training Smoking Cessation Intervention
Drug: Nicotine Replacement Therapy

Study type

Interventional

Funder types

Other

Identifiers

NCT05030766
20201296

Details and patient eligibility

About

The purpose of this study is to examine the feasibility, acceptability and effect of a combined smoking cessation intervention integrating contingency management (reward-based) strategies with Mindfulness training to identify the optimal dynamic strategy to promote smoking cessation among HIV patients.

Enrollment

95 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with HIV (based on self-report).
  • Be 18 years and older
  • Have smoked ≥ 5 cigarettes/day in the past year
  • Be interested in making a quit attempt in the next 30 days
  • Own a smartphone (apple/android), and plan to keep it active for the next 6 months
  • Able to consent
  • Have no plans to move in the next 6 months
  • Are not pregnant or planning to be pregnant in the following 6 months
  • Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements

Exclusion criteria

  • Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)
  • Are currently being treated for a psychiatric condition.
  • Are currently being treated for smoking cessation, alcoholism, or illicit drug use
  • Are adults unable to consent
  • Are individuals who are not yet adults
  • Are pregnant women
  • Are prisoners

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Sequential Assignment

Masking

None (Open label)

95 participants in 4 patient groups

MT plus NRT Group-Phase 1
Experimental group
Description:
Participants who receive the Mindfulness Training (MT) intervention for 4 weeks in addition to 6 weeks of Nicotine Replacement Therapy (NRT).These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.
Treatment:
Drug: Nicotine Replacement Therapy
Behavioral: Mindfulness Training Smoking Cessation Intervention
CM plus NRT Group-Phase1
Experimental group
Description:
Participants who receive the Contingency Management (CM) intervention for 4 weeks in addition to 6 weeks of NRT. These participants are responders (have quit smoking at the 1 month follow up) or non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive no additional intervention.
Treatment:
Drug: Nicotine Replacement Therapy
Behavioral: Contingency Management Smoking Cessation Intervention
MT plus NRT with additional CM Group-Phase2
Experimental group
Description:
Participants who received the MT intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional CM intervention for another 4 weeks.
Treatment:
Drug: Nicotine Replacement Therapy
Behavioral: Mindfulness Training Smoking Cessation Intervention
Behavioral: Contingency Management Smoking Cessation Intervention
CM plus NRT with additional MT Group-Phase2
Experimental group
Description:
Participants who received the CM intervention for 4 weeks with 6 weeks of NRT and are non-responders (those who have not quit smoking at the 1 month follow up) and randomized to receive an additional MT intervention for another 4 weeks.
Treatment:
Drug: Nicotine Replacement Therapy
Behavioral: Mindfulness Training Smoking Cessation Intervention
Behavioral: Contingency Management Smoking Cessation Intervention

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Laura McClure, MSPH; Taghrid Asfar, MD, MSPH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems